N
FMTX

Natixis’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Natixis’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-89,400
Closed -$1.78M – 1419
2022
Q3 		$1.78M Buy
+89,400
New +$1.18M 0.01% 632

Natixis's FMTX Position: Q4 2022 in Review

Natixis sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 89,400 shares — an estimated $1.78M sold.

Natixis first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $1.78M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Natixis reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Natixis sold 89,400 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $1.78M.
  • Natixis first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Natixis's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1.78M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Natixis's 13F filing for Q4 2022, filed 13 Feb 2023.